Adam Baker

• Conducted an internal investigation on behalf of the Special Committee of an international corporation concerning potential financial improprieties resulting in a restatement and violations of the Foreign Corrupt Practices Act, and represented the Special Committee in resulting parallel investigations by the DOJ and SEC.
• Represented a multinational financial services institution in investigations by the SEC and FINRA related to potential insider trading by current and former employees involved in a nonpublic M&A deal.
• Represented a multinational financial services institution in an internal investigation of potential violations of the Foreign Corrupt Practices Act and OFAC regulations by an employee who attempted to broker deals with the Iranian government.
• Represented the former CEO of a publicly-traded company in insider trading investigations by the DOJ and SEC.
• Represented a men’s college basketball coach in investigations by the DOJ and NCAA Enforcement regarding potential provision of payments and benefits to players.
• Represented a key figure in the “Bridgegate” matter in parallel investigations by the New Jersey Legislative Select Committee and U.S. Attorney’s Office, District of New Jersey.
• Represented a former Dewey & Leboeuf employee in the New York County District Attorney’s Office’s investigation of the downfall of the firm, successfully obtaining immunity for the client.

Adam Baker represents global financial institutions, healthcare and life sciences companies, and other public corporations in complex government and internal investigations and regulatory matters. He has extensive experience counseling clients facing investigations by the Department of Justice, Securities and Exchange Commission, State Attorneys General, Financial Industry Regulatory Authority, as well as other criminal and civil authorities. In particular, Adam has defended clients in matters implicating various federal laws and regulations, including insider trading, Foreign Corrupt Practices Act, Anti-Kickback Statute, healthcare fraud, and the Food, Drug & Cosmetic Act.

Previously, Adam served as a criminal Assistant United States Attorney in the Health Care Fraud/Opioid Abuse Prevention and Enforcement Unit in the District of New Jersey. In that role, he led a number of large-scale investigations and prosecutions of major pharmaceutical companies for healthcare fraud, diversion of controlled substances, and violations of the Federal Anti-Kickback Statute.  He also partnered with the DOJ’s Consumer Protection Branch on a significant investigation into potential violations by an opioid manufacturer and related individuals of the Food, Drug & Cosmetic Act.   

Prior to his government service, Adam was a Partner at another AmLaw 50 firm where he oversaw complex investigations and regulatory matters for financial institutions and its employees. 

Adam is active within the LGBTQ+ community. He helped found Boston Colleges’ first gay-straight alliance and served on his prior firm’s Diversity & LGBTQ+ committees. He serves on Boston College Law School’s national alumni board and formerly served as a Corp member for Teach For America.